Compound Planning, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1978879 NEW YORK, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$3,034,026

+$57,391 QoQ

Shares Held

6,108

-8.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#577

of 1,735 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Compound Planning, Inc. holds $8,958,284 across 15 Biotechnology names. VRTX ranks #1 (33.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	6,108	$3,034,026
2	REGN	Regeneron Pharmaceuticals, Inc.	1,253	$781,294
3	ARGX	Argenx SE	774	$718,093
4	RPRX	Royalty Pharma plc	12,784	$716,798
5	MRNA	Moderna, Inc.	8,776	$614,582
6	RVMD	Revolution Medicines, Inc.	2,787	$521,948
7	JAZZ	Jazz Pharmaceuticals plc	2,031	$489,409
8	EXEL	Exelixis, Inc.	7,541	$410,305

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,034,026	6,108	-8.4%	Shares	Sole	2026-08-04
2026-03-31	$2,976,635	6,666	+1.9%	Shares	Sole	2026-05-14
2025-12-31	$2,965,427	6,541	+174.4%	Shares	Defined	2026-02-19
2025-09-30	$933,669	2,384	-5.6%	Shares	Sole	2025-11-10
2025-06-30	$1,124,130	2,525	-11.2%	Shares	Sole	2025-08-14
2025-03-31	$1,378,343	2,843	+30.5%	Shares	Sole	2025-05-14
2024-12-31	$877,483	2,179	+13.7%	Shares	Sole	2025-01-17
2024-09-30	$891,558	1,917	+75.9%	Shares	Sole	2024-10-08
2024-06-30	$510,904	1,090	+23.6%	Shares	Sole	2024-07-26
2024-03-31	$368,684	882	+21.5%	Shares	Sole	2024-05-07
2023-12-31	$295,402	726	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.